GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Profit Margin (%) | 24.12 | 17.43 | 20.71 | 12.49 | 11.71 |
What is the latest Cash Profit Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Profit Margin |
|---|---|
| Mar2025 | 24.12 |
| Mar2024 | 17.43 |
| Mar2023 | 20.71 |
| Mar2022 | 12.49 |
| Mar2021 | 11.71 |
How is Cash Profit Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2025 | 24.12 | 38.38 | |
| Mar2024 | 17.43 | -15.84 | |
| Mar2023 | 20.71 | 65.81 | |
| Mar2022 | 12.49 | 6.66 | |
| Mar2021 | 11.71 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹44,010.1 Cr | 2.2% | 4.2% | 12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
4.2% |
12.7% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses